Stock Events

Stock Events

enGene Therapeutics (ENGN) Q2 2025 Earnings

Jun 12Confirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.51

-0.45

-0.38

-0.32

Details

Expected EPS

-0.497267

Actual EPS

-0.51

Surprise EPS

-0.01

Surprise Percent

-2.56%

Description

⁨enGene Therapeutics⁩ (⁦ENGN⁩) has reported earnings of ⁦-0.51⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.